
Chiltern International Limited proudly announces partnership with Karolinska Development in Sweden

Chiltern International Limited proudly announces partnership with Karolinska Development in Sweden

The newly formed ABIVAX is now working with the Cuban Center for Genetic Engineering and Biotechnology to develop therapeutic vaccines and antivirals.

Clinical program focused on reversing type 1 diabetes symptoms in patients diagnosed within six months of trial initiation

Regulations for the development of medical devices in Japan, China, and the UK will come under scrutiny

Clinical program focused on reversing type 1 diabetes symptoms in patients diagnosed within six months of trial initiation

Chiltern announces it was selected as the partner CRO for Karolinska Development

Therapeutically-Focused Clinical Development Team Leverages Technology-Amplified dCRO Model to Streamline Efficiencies, Reduce Development Costs

PAREXEL announced a group of initiatives that include a re-designed corporate website

Therapeutically-Focused Clinical Development Team Leverages Technology-Amplified dCRO Model to Streamline Efficiencies, Reduce Development Costs

"Your Journey. Our Mission." communicates company's new brand promise

Children with cancer are being denied new drugs because European Union rules are allowing companies to conduct trials on certain drugs only in adults, according to experts from The Institute of Cancer Research in London.

Theorem Clinical Research and Decision Driver Analytics have formed an alliance

Identification, reporting, and evaluation of protocol violations during a clinical trial is integral in adding value to the study data.

The clinical trial technological landscape continues to morph, as we are starting to see the emergence of novel technologies and techniques to enhance clinical trial strategies and productivity.

Information for Authors 2014

Theorem Clinical Research has announced the formation of a strategic alliance with Decision Driver Analytics

Industry news focusing on the people and organizations who work in the clinical trials profession.

Pharm Exec spoke with leaders in a resurgent patient movement about compassionate use access to new drugs, clinical trial participation policy, and the individual unmet needs of patients suffering from dementia and cancer.

Product helps to determine whether a drug candidate prolongs cardiac repolarization, a surrogate for potentially-fatal arrhythmias

Product helps to determine whether a drug candidate prolongs cardiac repolarization, a surrogate for potentially-fatal arrhythmias

ZRG Partners, Inc released its 4th Quarter Life Science Hiring Index.

ZRG Partners, Inc. announces the results of its fourth quarter Global Life Sciences Hiring Index

ROI from clinical research can suffer when too many research organizations seek to develop treatments for similar conditions and indications

New solution leverages linked data technologies to power the discovery of new scientific and strategic insights

ACRP GCP Courses Recognized for Good Clinical Practice by TransCelerate Biopharma

Rare Disease Management announced its rare disease clinical trial feasibility tool

First-of-its-Kind Facility to Begin Operations in Early Spring

New solution leverages linked data technologies to power the discovery of new scientific and strategic insights
